Subtopic Deep Dive
Berberine Pharmacokinetics and Bioavailability
Research Guide
What is Berberine Pharmacokinetics and Bioavailability?
Berberine Pharmacokinetics and Bioavailability studies the absorption, distribution, metabolism, and excretion of berberine, focusing on strategies to overcome its poor oral bioavailability through efflux inhibition and advanced formulations.
Berberine exhibits low oral bioavailability due to P-glycoprotein efflux and rapid metabolism. Research explores nanoparticle, liposome, and NADES formulations to enhance systemic exposure. Over 20 papers from 2012-2022 address these issues, with key works by Godugu et al. (2014, 146 citations) and Sut et al. (2017, 107 citations).
Why It Matters
Enhancing berberine bioavailability enables clinical translation for metabolic and cardiovascular therapies. Godugu et al. (2014) showed spray-dried formulations increased oral bioavailability and anticancer effects in animal models. Ai et al. (2021, 155 citations) reviewed pharmacokinetics supporting vascular disease applications. Allijn et al. (2017, 148 citations) demonstrated liposomal berberine reduced cardiac dysfunction post-myocardial infarction by improving delivery.
Key Research Challenges
Poor Oral Bioavailability
Berberine undergoes extensive first-pass metabolism and P-glycoprotein efflux, limiting plasma concentrations. Godugu et al. (2014) reported low systemic exposure without formulation aids. Liu et al. (2012, 50 citations) highlighted similar issues in traditional Chinese medicines.
Efflux Pump Inhibition
P-glycoprotein actively pumps berberine out of enterocytes, reducing absorption. Ai et al. (2021) discussed efflux mechanisms in vascular disease contexts. Strategies like co-administration inhibitors face toxicity risks.
Formulation Scalability
Nanoparticle and liposome systems improve bioavailability but challenge large-scale production. Allijn et al. (2017) used liposomes for cardiac delivery, yet clinical translation lags. Sut et al. (2017) advanced NADES but noted stability concerns.
Essential Papers
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antonio García‐Ríos, Samineh Jafari et al. · 2019 · Theranostics · 404 citations
Cardiovascular and metabolic diseases (CVMD) are the leading causes of death worldwide, underscoring the urgent necessity to develop new pharmacotherapies. Berberine (BBR) is an eminent component o...
Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
Andrea M. Tomko, Erin G. Whynot, Lee Ellis et al. · 2020 · Cancers · 208 citations
In recent years, and even more since its legalization in several jurisdictions, cannabis and the endocannabinoid system have received an increasing amount of interest related to their potential exp...
<p>The Anti-Cancer Mechanisms of Berberine: A Review</p>
Ye Wang, Yanfang Liu, Xinyang Du et al. · 2020 · Cancer Management and Research · 204 citations
Berberine (BBR) has been extensively studied in vivo and vitro experiments. BBR inhibits cell proliferation by regulating cell cycle and cell autophagy, and promoting cell apoptosis. BBR also inhib...
Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
Xiaopeng Ai, Peiling Yu, Li‐Xia Peng et al. · 2021 · Frontiers in Pharmacology · 155 citations
Traditional Chinese medicine plays a significant role in the treatment of various diseases and has attracted increasing attention for clinical applications. Vascular diseases affecting vasculature ...
Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction
Iris E. Allijn, Bertrand Czarny, Xiaoyuan Wang et al. · 2017 · Journal of Controlled Release · 148 citations
Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid
Chandraiah Godugu, Apurva R. Patel, Ravi Doddapaneni et al. · 2014 · PLoS ONE · 146 citations
Due to significant increase in oral bioavailability and superior anticancer effects, our results suggest that spray drying is a superior alternative formulation approach for oral delivery of BBR an...
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu et al. · 2022 · Molecules · 141 citations
Cancer has been a serious public health problem. Berberine is a famous natural compound from medicinal herbs and shows many bioactivities, such as antioxidant, anti-inflammatory, antidiabetic, anti...
Reading Guide
Foundational Papers
Start with Godugu et al. (2014, 146 citations) for spray-drying bioavailability gains, then Liu et al. (2012, 50 citations) for TCM absorption mechanisms.
Recent Advances
Ai et al. (2021, 155 citations) for PK in vascular applications; Sut et al. (2017, 107 citations) for NADES pharmacokinetics; Allijn et al. (2017, 148 citations) for liposomal delivery.
Core Methods
Pharmacokinetic modeling (AUC, Cmax via HPLC); formulations (spray-drying, liposomes, NADES); efflux inhibition assays (P-gp expression in Caco-2 cells).
How PapersFlow Helps You Research Berberine Pharmacokinetics and Bioavailability
Discover & Search
Research Agent uses searchPapers and exaSearch to find berberine bioavailability papers, then citationGraph on Godugu et al. (2014) reveals 146 citing works on spray-drying formulations. findSimilarPapers expands to Ai et al. (2021) for pharmacokinetics reviews.
Analyze & Verify
Analysis Agent applies readPaperContent to extract pharmacokinetic parameters from Sut et al. (2017), then runPythonAnalysis with pandas to plot AUC comparisons across NADES studies. verifyResponse via CoVe and GRADE grading confirms bioavailability claims against animal data.
Synthesize & Write
Synthesis Agent detects gaps in efflux inhibition strategies, flagging contradictions between Godugu et al. (2014) and Allijn et al. (2017). Writing Agent uses latexEditText, latexSyncCitations for PK models, and latexCompile to generate formatted reviews with exportMermaid for absorption pathway diagrams.
Use Cases
"Plot berberine bioavailability improvements from spray-drying vs liposomes in animal models"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Godugu 2014, Allijn 2017) → runPythonAnalysis (pandas/matplotlib AUC plots) → matplotlib figure of Cmax/AUC gains.
"Draft LaTeX review on berberine nanoparticle formulations for metabolic syndrome"
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure review) → latexSyncCitations (Ai 2021, Taghipour 2019) → latexCompile → PDF with cited PK tables.
"Find GitHub repos analyzing berberine PK modeling code"
Research Agent → paperExtractUrls (Sut 2017) → paperFindGithubRepo → githubRepoInspect → PK simulation scripts with Python PK libraries for bioavailability modeling.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'berberine bioavailability', structures report with PK summaries from Godugu (2014) to Sut (2017). DeepScan applies 7-step analysis: readPaperContent → runPythonAnalysis on AUC data → CoVe verification → GRADE grading of formulation efficacy. Theorizer generates hypotheses on combined NADES-liposome strategies from Ai et al. (2021).
Frequently Asked Questions
What defines Berberine Pharmacokinetics and Bioavailability?
It examines berberine's ADME properties, emphasizing low oral absorption due to P-gp efflux and metabolism, addressed by formulations like spray-drying (Godugu et al., 2014).
What methods improve berberine bioavailability?
Spray-drying (Godugu et al., 2014), liposomes (Allijn et al., 2017), and NADES (Sut et al., 2017) enhance absorption; pharmacokinetic modeling quantifies AUC increases in rodents.
What are key papers on this subtopic?
Foundational: Godugu et al. (2014, 146 citations) on spray-drying; Ai et al. (2021, 155 citations) reviews PK in vascular diseases; Sut et al. (2017, 107 citations) on NADES.
What open problems exist?
Human clinical PK data lags animal studies; scalable, non-toxic formulations need validation. Liu et al. (2012) notes TCM absorption challenges persist.
Research Berberine and alkaloids research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Berberine Pharmacokinetics and Bioavailability with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Berberine and alkaloids research Research Guide